Similar results were observed when we employed primary patient fibroblasts from XRCC1-mutated disease (Hoch et al., 2017), suggesting that increased PARP1 trapping during BER is also a feature of this human genetic disease (Figure S1C). The gene discussed is PARP1; the disease is hereditary disease.